EP0970186A4 - SPOoJ2 AUS STAPHYLOCOCCUS AUREUS - Google Patents

SPOoJ2 AUS STAPHYLOCOCCUS AUREUS

Info

Publication number
EP0970186A4
EP0970186A4 EP98943538A EP98943538A EP0970186A4 EP 0970186 A4 EP0970186 A4 EP 0970186A4 EP 98943538 A EP98943538 A EP 98943538A EP 98943538 A EP98943538 A EP 98943538A EP 0970186 A4 EP0970186 A4 EP 0970186A4
Authority
EP
European Patent Office
Prior art keywords
spooj2
staphylococcus aureus
aureus
staphylococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98943538A
Other languages
English (en)
French (fr)
Other versions
EP0970186A1 (de
Inventor
Martin K R Burnham
Andrew Fosberry
John E Hodgson
Elizabeth J Lawlor
Martin Rosenberg
Judith Ward
Deborah D Jaworski
Min Wang
Lisa K Shilling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/042,771 external-priority patent/US6080729A/en
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0970186A1 publication Critical patent/EP0970186A1/de
Publication of EP0970186A4 publication Critical patent/EP0970186A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP98943538A 1997-09-04 1998-09-04 SPOoJ2 AUS STAPHYLOCOCCUS AUREUS Withdrawn EP0970186A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5750997P 1997-09-04 1997-09-04
US57509P 1997-09-04
US09/042,771 US6080729A (en) 1998-03-17 1998-03-17 Spo0J2 of Staphylococcus aureus
US42771 1998-03-17
PCT/US1998/018365 WO1999011753A1 (en) 1997-09-04 1998-09-04 SpoOJ2 OF STAPHYLOCOCCUS AUREUS

Publications (2)

Publication Number Publication Date
EP0970186A1 EP0970186A1 (de) 2000-01-12
EP0970186A4 true EP0970186A4 (de) 2002-04-03

Family

ID=26719605

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98943538A Withdrawn EP0970186A4 (de) 1997-09-04 1998-09-04 SPOoJ2 AUS STAPHYLOCOCCUS AUREUS

Country Status (3)

Country Link
EP (1) EP0970186A4 (de)
JP (1) JP2002511768A (de)
WO (1) WO1999011753A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080729A (en) * 1998-03-17 2000-06-27 Smithkline Beecham Corporation Spo0J2 of Staphylococcus aureus

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786519A2 (de) * 1996-01-05 1997-07-30 Human Genome Sciences, Inc. Polynukleotide und Sequenzen aus Staphylococcus aureus
EP0841394A2 (de) * 1996-09-24 1998-05-13 Smithkline Beecham Corporation Polynukleotiden, Polypeptiden von Staphylococcus aureus und deren Anwendung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0786519A2 (de) * 1996-01-05 1997-07-30 Human Genome Sciences, Inc. Polynukleotide und Sequenzen aus Staphylococcus aureus
EP0841394A2 (de) * 1996-09-24 1998-05-13 Smithkline Beecham Corporation Polynukleotiden, Polypeptiden von Staphylococcus aureus und deren Anwendung

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EBI; 1 August 1992 (1992-08-01), OGASAWARA ET AL.: "SPO0J, Stage 0 sporulation protein J", XP002188359 *
DATABASE EMBL EBI; 1 October 1994 (1994-10-01), OGASAWARA ET AL.: "YYAA, Hypothetical 32.8 kDa protein in SPO0J-GIDB intergenic region", XP002188358 *
DATABASE EMBL EBI; 7 November 1991 (1991-11-07), OGASAWARA: "B.subtilis genes rpmH, rnpA, 50kd, gidA and gidB", XP002160456 *
See also references of WO9911753A1 *

Also Published As

Publication number Publication date
JP2002511768A (ja) 2002-04-16
WO1999011753A1 (en) 1999-03-11
EP0970186A1 (de) 2000-01-12

Similar Documents

Publication Publication Date Title
NO985643D0 (no) Antimikrobielle blandinger
EP1005356A4 (de) Neuartige antibiotika
PT1028961E (pt) Derivados de pleuromutilina como agentes antimicrobianos
PT1161420E (pt) Fungicidas de pirazol-carboxanilidas
FI971516A7 (fi) Antimikrobinen koostumus
DE69834429D1 (de) Antimikrobielle struktur
ATE225645T1 (de) Antimikrobielle abwischtücher
EP0913086A4 (de) Köder
DE69812370D1 (de) Landwirtschaftliche zusammensetzung
NO982071D0 (no) Benzoksazin-antimikrobielle midler
PT824535E (pt) Cefalosporinas antibacterianas
NO20020621D0 (no) Antibakterielle midler
FI933681L (fi) Antimikrobiellt medel
DE59809191D1 (de) Antimikrobieller Waschmittelzusatz
EP0961615A4 (de) Antimikrobielles mittel
DE69621471D1 (de) Kristalline antimikrobielle Zusammensetzung
EP0970186A4 (de) SPOoJ2 AUS STAPHYLOCOCCUS AUREUS
NO965109D0 (no) Antimikrobielle sammensetninger
DE69720492D1 (de) Insektizide zusammensetzungen
FI965230A7 (fi) Bakteerinvastaisia aineita
KR960013362A (ko) 항균제
DE69938586D1 (de) Insektizide dihydro-oxadiazine, -thiadiazine und -triazine
BR9603802A (pt) Combinações de compostos ativos fungicidas
ID23868A (id) Senyawa antimikroba
PL338671A1 (en) Treatment of staphylococcus aureus infections

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990913

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE DK FR GB IT LI NL

18W Application withdrawn

Withdrawal date: 20020205

A4 Supplementary search report drawn up and despatched

Effective date: 20020219

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE DK FR GB IT LI NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

R18W Application withdrawn (corrected)

Effective date: 20020205